Logo image of XHR

XENIA HOTELS & RESORTS INC (XHR) Stock Fundamental Analysis

NYSE:XHR - New York Stock Exchange, Inc. - US9840171030 - REIT - Currency: USD

9.89  -0.01 (-0.1%)

After market: 9.89 0 (0%)

Fundamental Rating

3

Overall XHR gets a fundamental rating of 3 out of 10. We evaluated XHR against 130 industry peers in the Diversified REITs industry. XHR has a bad profitability rating. Also its financial health evaluation is rather negative. XHR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year XHR was profitable.
XHR had a positive operating cash flow in the past year.
In multiple years XHR reported negative net income over the last 5 years.
XHR had a positive operating cash flow in 4 of the past 5 years.
XHR Yearly Net Income VS EBIT VS OCF VS FCFXHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of XHR (0.56%) is comparable to the rest of the industry.
The Return On Equity of XHR (1.27%) is comparable to the rest of the industry.
XHR has a Return On Invested Capital (2.49%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for XHR is in line with the industry average of 3.19%.
Industry RankSector Rank
ROA 0.56%
ROE 1.27%
ROIC 2.49%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
XHR Yearly ROA, ROE, ROICXHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 1.52%, XHR is in line with its industry, outperforming 44.62% of the companies in the same industry.
XHR's Profit Margin has declined in the last couple of years.
XHR has a Operating Margin of 8.18%. This is amonst the worse of the industry: XHR underperforms 80.00% of its industry peers.
XHR's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 54.32%, XHR is not doing good in the industry: 73.85% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of XHR has remained more or less at the same level.
Industry RankSector Rank
OM 8.18%
PM (TTM) 1.52%
GM 54.32%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
XHR Yearly Profit, Operating, Gross MarginsXHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

XHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for XHR has been reduced compared to 1 year ago.
The number of shares outstanding for XHR has been reduced compared to 5 years ago.
The debt/assets ratio for XHR has been reduced compared to a year ago.
XHR Yearly Shares OutstandingXHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
XHR Yearly Total Debt VS Total AssetsXHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

XHR has an Altman-Z score of 0.50. This is a bad value and indicates that XHR is not financially healthy and even has some risk of bankruptcy.
XHR has a Altman-Z score (0.50) which is in line with its industry peers.
The Debt to FCF ratio of XHR is 57.61, which is on the high side as it means it would take XHR, 57.61 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 57.61, XHR is in line with its industry, outperforming 56.92% of the companies in the same industry.
A Debt/Equity ratio of 1.07 is on the high side and indicates that XHR has dependencies on debt financing.
The Debt to Equity ratio of XHR (1.07) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 57.61
Altman-Z 0.5
ROIC/WACC0.33
WACC7.55%
XHR Yearly LT Debt VS Equity VS FCFXHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.78 indicates that XHR may have some problems paying its short term obligations.
XHR has a worse Current ratio (0.78) than 60.00% of its industry peers.
A Quick Ratio of 0.78 indicates that XHR may have some problems paying its short term obligations.
The Quick ratio of XHR (0.78) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
XHR Yearly Current Assets VS Current LiabilitesXHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The earnings per share for XHR have decreased strongly by -11.76% in the last year.
XHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.70% yearly.
XHR shows a small growth in Revenue. In the last year, the Revenue has grown by 1.32%.
The Revenue has been decreasing by -1.99% on average over the past years.
EPS 1Y (TTM)-11.76%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%-114.29%
Revenue 1Y (TTM)1.32%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%3.34%

3.2 Future

The Earnings Per Share is expected to grow by 42.53% on average over the next years. This is a very strong growth
Based on estimates for the next years, XHR will show a small growth in Revenue. The Revenue will grow by 2.51% on average per year.
EPS Next Y-30.2%
EPS Next 2Y22.17%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue Next Year3.62%
Revenue Next 2Y3.74%
Revenue Next 3Y2.51%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XHR Yearly Revenue VS EstimatesXHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
XHR Yearly EPS VS EstimatesXHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 65.93, the valuation of XHR can be described as expensive.
XHR's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.63. XHR is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 94.45, XHR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XHR is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.85, XHR is valued quite expensively.
Industry RankSector Rank
PE 65.93
Fwd PE 94.45
XHR Price Earnings VS Forward Price EarningsXHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XHR is valued a bit cheaper than 77.69% of the companies in the same industry.
XHR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 43.31
EV/EBITDA 10.58
XHR Per share dataXHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

XHR's earnings are expected to grow with 42.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.17%
EPS Next 3Y42.53%

4

5. Dividend

5.1 Amount

XHR has a Yearly Dividend Yield of 5.05%, which is a nice return.
The stock price of XHR dropped by -33.18% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 16.87, XHR has a dividend in line with its industry peers.
XHR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 5.05%

5.2 History

The dividend of XHR decreases each year by -15.89%.
XHR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of XHR decreased recently.
Dividend Growth(5Y)-15.89%
Div Incr Years1
Div Non Decr Years1
XHR Yearly Dividends per shareXHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

XHR pays out 304.02% of its income as dividend. This is not a sustainable payout ratio.
DP304.02%
EPS Next 2Y22.17%
EPS Next 3Y42.53%
XHR Yearly Income VS Free CF VS DividendXHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
XHR Dividend Payout.XHR Dividend Payout, showing the Payout Ratio.XHR Dividend Payout.PayoutRetained Earnings

XENIA HOTELS & RESORTS INC

NYSE:XHR (4/21/2025, 8:04:00 PM)

After market: 9.89 0 (0%)

9.89

-0.01 (-0.1%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)05-02 2025-05-02/bmo
Inst Owners96.16%
Inst Owner Change0.01%
Ins Owners0.91%
Ins Owner Change0.04%
Market Cap1.00B
Analysts78.18
Price Target15.81 (59.86%)
Short Float %2.95%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 5.05%
Yearly Dividend0.47
Dividend Growth(5Y)-15.89%
DP304.02%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-31 2025-03-31 (0.14)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-94.95%
Min EPS beat(2)-199.01%
Max EPS beat(2)9.11%
EPS beat(4)3
Avg EPS beat(4)3.89%
Min EPS beat(4)-199.01%
Max EPS beat(4)164.03%
EPS beat(8)4
Avg EPS beat(8)36.05%
EPS beat(12)7
Avg EPS beat(12)98.23%
EPS beat(16)9
Avg EPS beat(16)73.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.78%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-1.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.76%
Min Revenue beat(4)-1.98%
Max Revenue beat(4)2.48%
Revenue beat(8)2
Avg Revenue beat(8)-0.68%
Revenue beat(12)5
Avg Revenue beat(12)0.78%
Revenue beat(16)9
Avg Revenue beat(16)2.2%
PT rev (1m)-4.12%
PT rev (3m)-4.41%
EPS NQ rev (1m)-21.76%
EPS NQ rev (3m)-57.08%
EPS NY rev (1m)-65.44%
EPS NY rev (3m)-64.25%
Revenue NQ rev (1m)-1%
Revenue NQ rev (3m)-2.78%
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-1.18%
Valuation
Industry RankSector Rank
PE 65.93
Fwd PE 94.45
P/S 0.97
P/FCF 43.31
P/OCF 6.13
P/B 0.81
P/tB 0.81
EV/EBITDA 10.58
EPS(TTM)0.15
EY1.52%
EPS(NY)0.1
Fwd EY1.06%
FCF(TTM)0.23
FCFY2.31%
OCF(TTM)1.61
OCFY16.32%
SpS10.24
BVpS12.25
TBVpS12.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 1.27%
ROCE 3.15%
ROIC 2.49%
ROICexc 2.56%
ROICexgc 2.61%
OM 8.18%
PM (TTM) 1.52%
GM 54.32%
FCFM 2.23%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.99%
ROICexgc(5y)N/A
ROCE(3y)3.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.42%
ROICexc growth 3YN/A
ROICexc growth 5Y-6.41%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 57.61
Debt/EBITDA 6.24
Cap/Depr 109.17%
Cap/Sales 13.53%
Interest Coverage 0.98
Cash Conversion 76.59%
Profit Quality 146.97%
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z 0.5
F-Score6
WACC7.55%
ROIC/WACC0.33
Cap/Depr(3y)167.19%
Cap/Depr(5y)114.68%
Cap/Sales(3y)21.77%
Cap/Sales(5y)17.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.76%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%-114.29%
EPS Next Y-30.2%
EPS Next 2Y22.17%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue 1Y (TTM)1.32%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%3.34%
Revenue Next Year3.62%
Revenue Next 2Y3.74%
Revenue Next 3Y2.51%
Revenue Next 5YN/A
EBIT growth 1Y-12.68%
EBIT growth 3YN/A
EBIT growth 5Y-8.94%
EBIT Next Year198.42%
EBIT Next 3Y48.07%
EBIT Next 5YN/A
FCF growth 1Y-69.98%
FCF growth 3Y37.05%
FCF growth 5YN/A
OCF growth 1Y-17.34%
OCF growth 3Y58.91%
OCF growth 5Y-7.87%